|
| 35164524 | Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changes. | Aust N Z J Psychiatry | 2023 |
| 38037409 | The STAR*D Data Remain Strong: Reply to Pigott et al. | Am J Psychiatry | 2023 |
| 37585245 | Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy. | | 2023 |
| 37713557 | Recent developments pertaining to treatment-resistant depression: a 40-year perspective. | | 2023 |
| 37339227 | Enhanced amygdala-cingulate connectivity associates with better mood in both healthy and depressive individuals after sleep deprivation. | Proc Natl Acad Sci U S A | 2023 |
| 37273242 | Ketamine-assisted psychotherapy treatment of chronic pain and comorbid depression: a pilot study of two approaches. | | 2023 |
| 36640392 | Ongoing phase 2/3 trials of psychotropic drugs: is help finally on the way? | | 2023 |
| 36798983 | Objective sleep duration and response to combined pharmacotherapy and cognitive behavioral insomnia therapy among patients with comorbid depression and insomnia: a report from the TRIAD study. | J Clin Sleep Med | 2023 |
| 37115145 | Screening for Bipolar I Disorder and the Rapid Mood Screener: Results of a Nationwide Health Care Provider Survey. | Prim Care Companion CNS Disord | 2023 |
| 36921501 | Assessment of patient life engagement in major depressive disorder using items from the Inventory of Depressive Symptomatology Self-Report (IDS-SR). | | 2023 |
| 36855879 | A New Option for Depressed Patients Who Do Not Respond to Antidepressant Medications. | | 2023 |
| 37099968 | Effects of adjunctive brexpiprazole on patient life engagement in major depressive disorder: Post hoc analysis of Inventory of Depressive Symptomatology Self-Report data. | | 2023 |
| 37528698 | Providers' Use of Pharmacogenetic Testing to Inform Antidepressant Prescribing: Results of Qualitative Interviews. | Psychiatr Serv | 2023 |
| 35342199 | Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia). | | 2022 |
| 36048496 | Psychotherapy's Role for Treatment-Resistant Depression: Reply to Bartova et al. | American Journal of Psychiatry | 2022 |
| 35842108 | A comparison of prolonged exposure therapy, pharmacotherapy, and their combination for PTSD: What works best and for whom; study protocol for a randomized trial. | Contemp Clin Trials | 2022 |
| 35771513 | Do financial incentives increase mental health treatment engagement? A meta-analysis. | | 2022 |
| 35837681 | The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. | CNS Spectr | 2022 |
| 35819423 | Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. | JAMA | 2022 |
| 35689159 | Patient-reported outcome measures for life engagement in mental health: a systematic review. | Journal of Patient-Reported Outcomes | 2022 |
| 36339271 | Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies. | | 2022 |
| 36070581 | Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder. | Journal of Clinical Psychiatry | 2022 |
| 35937855 | Does Symptom Linkage Density Predict Outcomes in Cognitive Therapy for Recurrent Depression? | Journal of Psychopathology and Behavioral Assessment | 2022 |
| 35980255 | Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia. | Journal of Clinical Psychiatry | 2022 |
| 35921511 | Patient Functioning and Life Engagement: Unmet Needs in Major Depressive Disorder and Schizophrenia. | Journal of Clinical Psychiatry | 2022 |
| 35721815 | Commentary on the Hamilton Rating Scale for Depression: 60+ Years Old and Still Relevant to the Assessment of Antidepressant Treatment Outcomes. | | 2022 |
| 33794674 | Stability and Change in Relations Between Personality Traits and the Interpersonal Problems Circumplex During Cognitive Therapy for Recurrent Depression. | Assessment | 2022 |
| 34257409 | Treatment resistance in psychiatry: state of the art and new directions. | Molecular Psychiatry | 2022 |
| 34991768 | Clinical research challenges posed by difficult-to-treat depression. | Psychol Med | 2022 |
| 34986431 | Combinatorial pharmacogenomic algorithm is predictive of sertraline metabolism in patients with major depressive disorder. | Psychiatry Res | 2022 |
| 34860349 | Ruminative reflection is associated with anticorrelations between the orbitofrontal cortex and the default mode network in depression: implications for repetitive transcranial magnetic stimulation. | Brain Imaging Behav | 2022 |
| 34625993 | Addressing anhedonia to increase depression treatment engagement. | British Journal of Clinical Psychology | 2022 |
| 34775120 | Levels of depressed mood and low interest for two years after response to cognitive therapy for recurrent depression. | Behaviour Research and Therapy | 2022 |
| 34952123 | Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response. | J Affect Disord | 2022 |
| 34767967 | Anatomical and fMRI-network comparison of multiple DLPFC targeting strategies for repetitive transcranial magnetic stimulation treatment of depression. | Brain Stimul | 2022 |
| 35131363 | Vortioxetine 5, 10, and 20 mg significantly reduces the risk of relapse compared with placebo in patients with remitted major depressive disorder: The RESET study. | Journal of Affective Disorders | 2022 |
| 35105164 | The Neglected Role of Psychotherapy for Treatment-Resistant Depression. | American Journal of Psychiatry | 2022 |
| 35243620 | Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder. | Acta Psychiatr Scand | 2022 |
| 34416369 | Design of the National Adaptive Trial for PTSD-related Insomnia (NAP Study), VA Cooperative Study Program (CSP) #2016. | Contemp Clin Trials | 2021 |
| 31747982 | Response to the letter entitled "Tachyphylaxis and Desensitization Depression" by Richard Skaff. | CNS Spectrums | 2021 |
| 33752227 | Strategies for Optimizing the Treatment of Major Depressive Disorder. | Journal of Family Practice | 2021 |
| 34293233 | The effect of esketamine in patients with treatment-resistant depression with and without comorbid anxiety symptoms or disorder. | Depression and Anxiety | 2021 |
| 33853197 | The natural history of insomnia: Does sleep extension differentiate between those that do and do not develop chronic insomnia? | Journal of Sleep Research | 2021 |
| 33677183 | Evaluation of MADRS severity thresholds in patients with bipolar depression. | Journal of Affective Disorders | 2021 |
| 33726522 | Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. | Am J Psychiatry | 2021 |
| 34092819 | Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder. | Psychopharmacol Bull | 2021 |
| 33601706 | Prevalence of predicted gene-drug interactions for antidepressants in the treatment of major depressive disorder in the Precision Medicine in Mental Health Care Study. | J Affect Disord | 2021 |
| 33866020 | Targeting location relates to treatment response in active but not sham rTMS stimulation. | Brain Stimul | 2021 |
| 34324636 | Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder: A Phase 2b, Randomized, Placebo-Controlled, Adaptive Dose-Finding Study. | International Journal of Neuropsychopharmacology | 2021 |
| 33316457 | Study design and implementation of the PRecision Medicine In MEntal health Care (PRIME Care) Trial. | Contemp Clin Trials | 2021 |